Healio

Etripamil reduces ventricular rate in patients with AF

Please provide your email address to receive an email when new articles are posted on . Etripamil reduced ventricular rate in patients with atrial fibrillation and rapid ventricular rate compared with ...
Oklahoma's News

Milestone Pharmaceuticals to Host Virtual Key Opinion Leader Event on Etripamil for the Treatment of Atrial Fibrillation with Rapid Ventricular Rate

MONTREAL and CHARLOTTE, N.C., May 8, 2023 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative ...
Nasdaq

Milestone Pharmaceuticals Presents Positive Results from ReVeRA Phase 2 Study of Etripamil in AFib-RVR at the American Heart Association Scientific Sessions 2023

Etripamil, an investigational drug, showed statistically significant reduction in ventricular rate by 30 beats per minute for episodes of atrial fibrillation with rapid ventricular rate (p 0.0001) ...
TCTMD

Etripamil Nasal Spray Shows Promise for AF Patients With Rapid Ventricular Rate

PHILADELPHIA, PA—Etripamil nasal spray (Milestone Pharmaceuticals) appears to provide quick relief for patients with atrial fibrillation (AF) accompanied by a rapid ventricular rate, according to ...
Odessa American

Global Atrial Fibrillation Pipeline Insight Report 2021 – ResearchAndMarkets.com

The "Atrial Fibrillation – Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com’s offering. This "Atrial Fibrillation – Pipeline Insight, 2021," report provides ...